

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | folic acid-containing compound biosynthetic process (GO:0009396) | 5.38182817 |
| 2 | heme biosynthetic process (GO:0006783) | 5.07704294 |
| 3 | DNA deamination (GO:0045006) | 4.95927025 |
| 4 | folic acid metabolic process (GO:0046655) | 4.90757665 |
| 5 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.79749448 |
| 6 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.66062372 |
| 7 | DNA unwinding involved in DNA replication (GO:0006268) | 4.49623812 |
| 8 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.47725693 |
| 9 | heme metabolic process (GO:0042168) | 4.43915208 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 4.40770059 |
| 11 | lysine catabolic process (GO:0006554) | 4.40728491 |
| 12 | lysine metabolic process (GO:0006553) | 4.40728491 |
| 13 | DNA replication initiation (GO:0006270) | 4.38549996 |
| 14 | hemoglobin metabolic process (GO:0020027) | 4.37702524 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.27502642 |
| 16 | DNA strand elongation (GO:0022616) | 4.20206693 |
| 17 | porphyrin-containing compound biosynthetic process (GO:0006779) | 4.19155688 |
| 18 | viral transcription (GO:0019083) | 4.13465910 |
| 19 | translational termination (GO:0006415) | 4.10036909 |
| 20 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.89627782 |
| 21 | protein autoprocessing (GO:0016540) | 3.86154101 |
| 22 | formation of translation preinitiation complex (GO:0001731) | 3.85015711 |
| 23 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.83169402 |
| 24 | translational elongation (GO:0006414) | 3.82455371 |
| 25 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.79436695 |
| 26 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.77918228 |
| 27 | proline biosynthetic process (GO:0006561) | 3.77243878 |
| 28 | DNA ligation (GO:0006266) | 3.76561949 |
| 29 | porphyrin-containing compound metabolic process (GO:0006778) | 3.69956268 |
| 30 | tetrapyrrole biosynthetic process (GO:0033014) | 3.62864253 |
| 31 | DNA replication checkpoint (GO:0000076) | 3.62755893 |
| 32 | regulation of mitochondrial translation (GO:0070129) | 3.62091618 |
| 33 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.61641015 |
| 34 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.61641015 |
| 35 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.58295342 |
| 36 | one-carbon metabolic process (GO:0006730) | 3.55385644 |
| 37 | DNA topological change (GO:0006265) | 3.53017824 |
| 38 | maturation of SSU-rRNA (GO:0030490) | 3.48987985 |
| 39 | translational initiation (GO:0006413) | 3.48318959 |
| 40 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.47497868 |
| 41 | telomere maintenance via recombination (GO:0000722) | 3.47386341 |
| 42 | granulocyte differentiation (GO:0030851) | 3.45832514 |
| 43 | tetrahydrofolate metabolic process (GO:0046653) | 3.44784759 |
| 44 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.44220994 |
| 45 | IMP biosynthetic process (GO:0006188) | 3.44209945 |
| 46 | Golgi transport vesicle coating (GO:0048200) | 3.41441956 |
| 47 | COPI coating of Golgi vesicle (GO:0048205) | 3.41441956 |
| 48 | establishment of viral latency (GO:0019043) | 3.39500771 |
| 49 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.37577701 |
| 50 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.35327487 |
| 51 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.34613518 |
| 52 | mitotic nuclear envelope disassembly (GO:0007077) | 3.34576552 |
| 53 | protein targeting to ER (GO:0045047) | 3.32726772 |
| 54 | cotranslational protein targeting to membrane (GO:0006613) | 3.32631946 |
| 55 | folic acid-containing compound metabolic process (GO:0006760) | 3.32585021 |
| 56 | protein maturation by protein folding (GO:0022417) | 3.28512067 |
| 57 | cysteine metabolic process (GO:0006534) | 3.25251589 |
| 58 | positive regulation of hematopoietic progenitor cell differentiation (GO:1901534) | 3.23980422 |
| 59 | nucleobase biosynthetic process (GO:0046112) | 3.21996666 |
| 60 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.21255186 |
| 61 | glycine metabolic process (GO:0006544) | 3.20406030 |
| 62 | definitive hemopoiesis (GO:0060216) | 3.19758815 |
| 63 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 3.19674450 |
| 64 | protein localization to endoplasmic reticulum (GO:0070972) | 3.18397197 |
| 65 | mitotic recombination (GO:0006312) | 3.17043853 |
| 66 | tetrapyrrole metabolic process (GO:0033013) | 3.16962002 |
| 67 | viral life cycle (GO:0019058) | 3.16422210 |
| 68 | pentose-phosphate shunt (GO:0006098) | 3.16059505 |
| 69 | nuclear pore complex assembly (GO:0051292) | 3.15438858 |
| 70 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.15417251 |
| 71 | cellular protein complex disassembly (GO:0043624) | 3.13436479 |
| 72 | serine family amino acid biosynthetic process (GO:0009070) | 3.11968991 |
| 73 | nuclear envelope disassembly (GO:0051081) | 3.10525681 |
| 74 | membrane disassembly (GO:0030397) | 3.10525681 |
| 75 | IMP metabolic process (GO:0046040) | 3.09804568 |
| 76 | translesion synthesis (GO:0019985) | 3.05891862 |
| 77 | ribosome biogenesis (GO:0042254) | 3.05704371 |
| 78 | regulation of translational termination (GO:0006449) | 3.04825883 |
| 79 | pseudouridine synthesis (GO:0001522) | 3.04578610 |
| 80 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.03347317 |
| 81 | proteasome assembly (GO:0043248) | 3.01915610 |
| 82 | protein localization to kinetochore (GO:0034501) | 3.01401795 |
| 83 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.00152173 |
| 84 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.00152173 |
| 85 | telomere maintenance via telomere lengthening (GO:0010833) | 2.99476419 |
| 86 | erythrocyte maturation (GO:0043249) | 2.98169144 |
| 87 | mitotic chromosome condensation (GO:0007076) | 2.97060523 |
| 88 | erythrocyte development (GO:0048821) | 2.95006344 |
| 89 | pteridine-containing compound metabolic process (GO:0042558) | 2.94498890 |
| 90 | viral mRNA export from host cell nucleus (GO:0046784) | 2.94322871 |
| 91 | negative regulation of RNA splicing (GO:0033119) | 2.93205547 |
| 92 | ribosomal small subunit biogenesis (GO:0042274) | 2.92973492 |
| 93 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.92081428 |
| 94 | regulation of protein heterodimerization activity (GO:0043497) | 2.91888016 |
| 95 | nucleoside salvage (GO:0043174) | 2.91788733 |
| 96 | nuclear pore organization (GO:0006999) | 2.90742919 |
| 97 | spliceosomal snRNP assembly (GO:0000387) | 2.88349397 |
| 98 | mitotic metaphase plate congression (GO:0007080) | 2.85708617 |
| 99 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.80933653 |
| 100 | protein localization to chromosome, centromeric region (GO:0071459) | 2.80390620 |
| 101 | protein complex disassembly (GO:0043241) | 2.79264286 |
| 102 | mitotic sister chromatid segregation (GO:0000070) | 2.78972241 |
| 103 | ribosomal large subunit biogenesis (GO:0042273) | 2.78678540 |
| 104 | CENP-A containing nucleosome assembly (GO:0034080) | 2.78547646 |
| 105 | NADPH regeneration (GO:0006740) | 2.77720477 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.75247142 |
| 107 | purine nucleobase biosynthetic process (GO:0009113) | 2.74633776 |
| 108 | purine ribonucleotide transport (GO:0015868) | 2.74092835 |
| 109 | oxidative phosphorylation (GO:0006119) | 2.73616429 |
| 110 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.72806575 |
| 111 | ribosome assembly (GO:0042255) | 2.71991764 |
| 112 | translation (GO:0006412) | 2.71777258 |
| 113 | serine family amino acid metabolic process (GO:0009069) | 2.71447949 |
| 114 | chromatin remodeling at centromere (GO:0031055) | 2.70625628 |
| 115 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.70590339 |
| 116 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.70198058 |
| 117 | non-recombinational repair (GO:0000726) | 2.69863505 |
| 118 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.69863505 |
| 119 | maternal placenta development (GO:0001893) | 2.69407676 |
| 120 | regulation of translational fidelity (GO:0006450) | 2.68808982 |
| 121 | sister chromatid segregation (GO:0000819) | 2.67803028 |
| 122 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.67035593 |
| 123 | pigment biosynthetic process (GO:0046148) | 2.66914551 |
| 124 | purine-containing compound salvage (GO:0043101) | 2.65281189 |
| 125 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.64351806 |
| 126 | UMP biosynthetic process (GO:0006222) | 2.64351806 |
| 127 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.64351806 |
| 128 | UMP metabolic process (GO:0046049) | 2.64351806 |
| 129 | macromolecular complex disassembly (GO:0032984) | 2.63455468 |
| 130 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.59554082 |
| 131 | establishment of integrated proviral latency (GO:0075713) | 2.58239435 |
| 132 | oxygen transport (GO:0015671) | 2.58023865 |
| 133 | DNA replication-independent nucleosome organization (GO:0034724) | 2.57595509 |
| 134 | regulation of histone H3-K9 methylation (GO:0051570) | 2.56333555 |
| 135 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.55808099 |
| 136 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.55317730 |
| 137 | tRNA aminoacylation for protein translation (GO:0006418) | 2.55214164 |
| 138 | proline metabolic process (GO:0006560) | 2.53853988 |
| 139 | histone exchange (GO:0043486) | 2.53155415 |
| 140 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.50202775 |
| 141 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.49046930 |
| 142 | pigment metabolic process (GO:0042440) | 2.49013486 |
| 143 | base-excision repair (GO:0006284) | 2.48356049 |
| 144 | mitotic G2/M transition checkpoint (GO:0044818) | 2.46206309 |
| 145 | negative regulation of chromosome segregation (GO:0051985) | 2.46071758 |
| 146 | iron ion import (GO:0097286) | 2.43861935 |
| 147 | tRNA aminoacylation (GO:0043039) | 2.43426498 |
| 148 | amino acid activation (GO:0043038) | 2.43426498 |
| 149 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.43076831 |
| 150 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.43076831 |
| 151 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.43076831 |
| 152 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.43076831 |
| 153 | negative regulation of sister chromatid segregation (GO:0033046) | 2.43076831 |
| 154 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.42986198 |
| 155 | kinetochore organization (GO:0051383) | 2.41478289 |
| 156 | blood coagulation, intrinsic pathway (GO:0007597) | 2.38892493 |
| 157 | regulation of response to osmotic stress (GO:0047484) | 2.37893565 |
| 158 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.37829753 |
| 159 | nuclear envelope reassembly (GO:0031468) | 2.36864093 |
| 160 | mitotic nuclear envelope reassembly (GO:0007084) | 2.36864093 |
| 161 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.36683860 |
| 162 | negative regulation of ligase activity (GO:0051352) | 2.34699017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.39483222 |
| 2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.98700443 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.06243995 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.10886740 |
| 5 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.81681177 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.72759395 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69746443 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.65371385 |
| 9 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.46590194 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.39016408 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.34279670 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.33010023 |
| 13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.28223376 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27020449 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.26711263 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.21839694 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.16631766 |
| 18 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.16452154 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.14735255 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.12921075 |
| 21 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.05546482 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.02473628 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.98128014 |
| 24 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.97757629 |
| 25 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.97501545 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.93969063 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.86432956 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85947919 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.85218503 |
| 30 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.84475778 |
| 31 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.83813998 |
| 32 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.80866976 |
| 33 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.79054147 |
| 34 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.75977110 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.72531392 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.72504339 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.69360214 |
| 38 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.68356181 |
| 39 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67218856 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62924836 |
| 41 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.62297915 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59507776 |
| 43 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.54621760 |
| 44 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53815781 |
| 45 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.52581010 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49985192 |
| 47 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.49404363 |
| 48 | GATA1_19941826_ChIP-Seq_K562_Human | 1.48923053 |
| 49 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48263389 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44764445 |
| 51 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43456870 |
| 52 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40771884 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40658440 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.37677025 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35522467 |
| 56 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33957652 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.33709502 |
| 58 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33072005 |
| 59 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32549613 |
| 60 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.32484726 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.32046984 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32031754 |
| 63 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31297182 |
| 64 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.31290527 |
| 65 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.30873825 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.30376104 |
| 67 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.30183169 |
| 68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.29002805 |
| 69 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.27096112 |
| 70 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.25762065 |
| 71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.25424152 |
| 72 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.25398145 |
| 73 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23855738 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.23681116 |
| 75 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23584664 |
| 76 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22849613 |
| 77 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.22039000 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20650769 |
| 79 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19597640 |
| 80 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19341762 |
| 81 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.18173940 |
| 82 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18156693 |
| 83 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17781412 |
| 84 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17692583 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16729904 |
| 86 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.15708770 |
| 87 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15025607 |
| 88 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.13455339 |
| 89 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.11889310 |
| 90 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.10021865 |
| 91 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.08652451 |
| 92 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.07498056 |
| 93 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07275106 |
| 94 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06522563 |
| 95 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05415451 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04291113 |
| 97 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03709577 |
| 98 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02682642 |
| 99 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02464904 |
| 100 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.01633191 |
| 101 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01198367 |
| 102 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.01123270 |
| 103 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.00627824 |
| 104 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.00527186 |
| 105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00435941 |
| 106 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.00047497 |
| 107 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.98539575 |
| 108 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.98245696 |
| 109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98034535 |
| 110 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.97253315 |
| 111 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96382822 |
| 112 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.94161045 |
| 113 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.94160064 |
| 114 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.93719260 |
| 115 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93589597 |
| 116 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92916954 |
| 117 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.92447502 |
| 118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91987249 |
| 119 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91384917 |
| 120 | MAF_26560356_Chip-Seq_TH1_Human | 0.89337515 |
| 121 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.89278190 |
| 122 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.88515345 |
| 123 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88447139 |
| 124 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87837860 |
| 125 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87310193 |
| 126 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.87224008 |
| 127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.86290334 |
| 128 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.85527573 |
| 129 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.85121782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 5.00112638 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.22157946 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.18966192 |
| 4 | MP0006054_spinal_hemorrhage | 4.17002178 |
| 5 | MP0004147_increased_porphyrin_level | 3.94533118 |
| 6 | MP0005360_urolithiasis | 3.72781401 |
| 7 | MP0003693_abnormal_embryo_hatching | 3.16622653 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 3.00986996 |
| 9 | MP0009697_abnormal_copulation | 2.98505838 |
| 10 | MP0003111_abnormal_nucleus_morphology | 2.74011883 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.58875967 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.58875967 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.58466721 |
| 14 | MP0005085_abnormal_gallbladder_physiolo | 2.54461620 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.38531124 |
| 16 | MP0009840_abnormal_foam_cell | 2.34443102 |
| 17 | MP0003077_abnormal_cell_cycle | 2.30941853 |
| 18 | MP0005365_abnormal_bile_salt | 2.10619219 |
| 19 | MP0003186_abnormal_redox_activity | 2.05727213 |
| 20 | MP0001529_abnormal_vocalization | 1.96397116 |
| 21 | MP0000490_abnormal_crypts_of | 1.88542755 |
| 22 | MP0003315_abnormal_perineum_morphology | 1.84722655 |
| 23 | MP0008875_abnormal_xenobiotic_pharmacok | 1.83699359 |
| 24 | MP0010352_gastrointestinal_tract_polyps | 1.80472688 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.76369038 |
| 26 | MP0008057_abnormal_DNA_replication | 1.73589221 |
| 27 | MP0004272_abnormal_basement_membrane | 1.73318312 |
| 28 | MP0008789_abnormal_olfactory_epithelium | 1.71402767 |
| 29 | MP0003941_abnormal_skin_development | 1.64253148 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.61174745 |
| 31 | MP0010329_abnormal_lipoprotein_level | 1.60557883 |
| 32 | MP0008007_abnormal_cellular_replicative | 1.60318420 |
| 33 | MP0008995_early_reproductive_senescence | 1.58651696 |
| 34 | MP0010307_abnormal_tumor_latency | 1.55577200 |
| 35 | MP0003890_abnormal_embryonic-extraembry | 1.55191222 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.54899825 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.53834853 |
| 38 | MP0001730_embryonic_growth_arrest | 1.51344518 |
| 39 | MP0005499_abnormal_olfactory_system | 1.48952916 |
| 40 | MP0005394_taste/olfaction_phenotype | 1.48952916 |
| 41 | MP0009333_abnormal_splenocyte_physiolog | 1.47379002 |
| 42 | MP0008058_abnormal_DNA_repair | 1.46281823 |
| 43 | MP0003252_abnormal_bile_duct | 1.45612272 |
| 44 | MP0005083_abnormal_biliary_tract | 1.43290178 |
| 45 | MP0005451_abnormal_body_composition | 1.42805094 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 1.42078202 |
| 47 | MP0000609_abnormal_liver_physiology | 1.39120004 |
| 48 | MP0004808_abnormal_hematopoietic_stem | 1.37554385 |
| 49 | MP0001666_abnormal_nutrient_absorption | 1.35433140 |
| 50 | MP0000350_abnormal_cell_proliferation | 1.34963108 |
| 51 | MP0005319_abnormal_enzyme/_coenzyme | 1.31308976 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.26899824 |
| 53 | MP0000598_abnormal_liver_morphology | 1.26427501 |
| 54 | MP0005332_abnormal_amino_acid | 1.25251486 |
| 55 | MP0001293_anophthalmia | 1.24978453 |
| 56 | MP0002084_abnormal_developmental_patter | 1.24550335 |
| 57 | MP0002398_abnormal_bone_marrow | 1.24086186 |
| 58 | MP0009384_cardiac_valve_regurgitation | 1.21868939 |
| 59 | MP0002085_abnormal_embryonic_tissue | 1.19354452 |
| 60 | MP0002019_abnormal_tumor_incidence | 1.16359638 |
| 61 | MP0002080_prenatal_lethality | 1.15371234 |
| 62 | MP0006035_abnormal_mitochondrial_morpho | 1.15370593 |
| 63 | MP0002722_abnormal_immune_system | 1.13568158 |
| 64 | MP0001915_intracranial_hemorrhage | 1.12607014 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.12240899 |
| 66 | MP0003123_paternal_imprinting | 1.11853008 |
| 67 | MP0000313_abnormal_cell_death | 1.11840902 |
| 68 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11527481 |
| 69 | MP0010234_abnormal_vibrissa_follicle | 1.10803998 |
| 70 | MP0001853_heart_inflammation | 1.08182088 |
| 71 | MP0000358_abnormal_cell_content/ | 1.07271578 |
| 72 | MP0001661_extended_life_span | 1.07172200 |
| 73 | MP0008932_abnormal_embryonic_tissue | 1.06989775 |
| 74 | MP0000685_abnormal_immune_system | 1.06762951 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.06036625 |
| 76 | MP0001727_abnormal_embryo_implantation | 1.04706352 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 1.04466813 |
| 78 | MP0000516_abnormal_urinary_system | 1.03988574 |
| 79 | MP0005367_renal/urinary_system_phenotyp | 1.03988574 |
| 80 | MP0001764_abnormal_homeostasis | 1.03407362 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.03183052 |
| 82 | MP0005623_abnormal_meninges_morphology | 1.02340086 |
| 83 | MP0002429_abnormal_blood_cell | 1.01187591 |
| 84 | MP0001697_abnormal_embryo_size | 1.00047875 |
| 85 | MP0000465_gastrointestinal_hemorrhage | 0.99645762 |
| 86 | MP0008469_abnormal_protein_level | 0.99517967 |
| 87 | MP0002086_abnormal_extraembryonic_tissu | 0.97547566 |
| 88 | MP0002697_abnormal_eye_size | 0.94284001 |
| 89 | MP0002132_abnormal_respiratory_system | 0.92754993 |
| 90 | MP0005384_cellular_phenotype | 0.91350314 |
| 91 | MP0003436_decreased_susceptibility_to | 0.91253938 |
| 92 | MP0000537_abnormal_urethra_morphology | 0.90898518 |
| 93 | MP0009643_abnormal_urine_homeostasis | 0.88209677 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.87191510 |
| 95 | MP0009764_decreased_sensitivity_to | 0.87026079 |
| 96 | MP0000703_abnormal_thymus_morphology | 0.86483113 |
| 97 | MP0002938_white_spotting | 0.86215202 |
| 98 | MP0003763_abnormal_thymus_physiology | 0.85922809 |
| 99 | MP0010030_abnormal_orbit_morphology | 0.85049097 |
| 100 | MP0000428_abnormal_craniofacial_morphol | 0.84847424 |
| 101 | MP0008260_abnormal_autophagy | 0.82810191 |
| 102 | MP0004947_skin_inflammation | 0.81141623 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80891278 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.80160209 |
| 105 | MP0005023_abnormal_wound_healing | 0.79985298 |
| 106 | MP0003121_genomic_imprinting | 0.79107610 |
| 107 | MP0010368_abnormal_lymphatic_system | 0.78519777 |
| 108 | MP0001243_abnormal_dermal_layer | 0.78418434 |
| 109 | MP0000604_amyloidosis | 0.78140978 |
| 110 | MP0005266_abnormal_metabolism | 0.77959880 |
| 111 | MP0005621_abnormal_cell_physiology | 0.77754103 |
| 112 | MP0005380_embryogenesis_phenotype | 0.76377634 |
| 113 | MP0001672_abnormal_embryogenesis/_devel | 0.76377634 |
| 114 | MP0003172_abnormal_lysosome_physiology | 0.76276916 |
| 115 | MP0009763_increased_sensitivity_to | 0.76186803 |
| 116 | MP0003385_abnormal_body_wall | 0.75626267 |
| 117 | MP0009703_decreased_birth_body | 0.75323021 |
| 118 | MP0008004_abnormal_stomach_pH | 0.74925635 |
| 119 | MP0003984_embryonic_growth_retardation | 0.74561414 |
| 120 | MP0009672_abnormal_birth_weight | 0.74235272 |
| 121 | MP0002092_abnormal_eye_morphology | 0.73695990 |
| 122 | MP0003942_abnormal_urinary_system | 0.72617649 |
| 123 | MP0002088_abnormal_embryonic_growth/wei | 0.72605268 |
| 124 | MP0000716_abnormal_immune_system | 0.72253890 |
| 125 | MP0000477_abnormal_intestine_morphology | 0.71937471 |
| 126 | MP0003786_premature_aging | 0.71802030 |
| 127 | MP0003943_abnormal_hepatobiliary_system | 0.71753949 |
| 128 | MP0009931_abnormal_skin_appearance | 0.71186929 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.70973151 |
| 130 | MP0000858_altered_metastatic_potential | 0.70949479 |
| 131 | MP0004197_abnormal_fetal_growth/weight/ | 0.70840190 |
| 132 | MP0002233_abnormal_nose_morphology | 0.69523584 |
| 133 | MP0003718_maternal_effect | 0.68393747 |
| 134 | MP0003195_calcinosis | 0.68085975 |
| 135 | MP0003011_delayed_dark_adaptation | 0.67987060 |
| 136 | MP0000467_abnormal_esophagus_morphology | 0.67174723 |
| 137 | MP0003868_abnormal_feces_composition | 0.66986126 |
| 138 | MP0000566_synostosis | 0.66810399 |
| 139 | MP0004019_abnormal_vitamin_homeostasis | 0.66425072 |
| 140 | MP0008873_increased_physiological_sensi | 0.66407265 |
| 141 | MP0005501_abnormal_skin_physiology | 0.66186733 |
| 142 | MP0008770_decreased_survivor_rate | 0.66181891 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.66120597 |
| 144 | MP0009785_altered_susceptibility_to | 0.65072938 |
| 145 | MP0005084_abnormal_gallbladder_morpholo | 0.64616664 |
| 146 | MP0001286_abnormal_eye_development | 0.64123674 |
| 147 | MP0005376_homeostasis/metabolism_phenot | 0.63639744 |
| 148 | MP0005025_abnormal_response_to | 0.63382739 |
| 149 | MP0008775_abnormal_heart_ventricle | 0.62446739 |
| 150 | MP0005220_abnormal_exocrine_pancreas | 0.61388028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 8.53794598 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 6.44981217 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 6.19707935 |
| 4 | Poikilocytosis (HP:0004447) | 4.46336403 |
| 5 | Reticulocytosis (HP:0001923) | 4.46314291 |
| 6 | Acanthocytosis (HP:0001927) | 4.37382964 |
| 7 | Increased mean platelet volume (HP:0011877) | 4.04903183 |
| 8 | Abnormality of reticulocytes (HP:0004312) | 3.92066705 |
| 9 | Increased serum ferritin (HP:0003281) | 3.62162251 |
| 10 | Hyperbilirubinemia (HP:0002904) | 3.53564423 |
| 11 | Abnormal platelet volume (HP:0011876) | 3.45381155 |
| 12 | Hypobetalipoproteinemia (HP:0003563) | 3.33537108 |
| 13 | Pallor (HP:0000980) | 3.31203000 |
| 14 | Abnormality of iron homeostasis (HP:0011031) | 3.27603790 |
| 15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.23483289 |
| 16 | Spastic diplegia (HP:0001264) | 3.16318231 |
| 17 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.13935303 |
| 18 | Oral leukoplakia (HP:0002745) | 3.13862295 |
| 19 | Birth length less than 3rd percentile (HP:0003561) | 3.10329118 |
| 20 | Microretrognathia (HP:0000308) | 2.99196317 |
| 21 | Reticulocytopenia (HP:0001896) | 2.95626552 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.90820457 |
| 23 | Macrocytic anemia (HP:0001972) | 2.86618211 |
| 24 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.81647383 |
| 25 | Microvesicular hepatic steatosis (HP:0001414) | 2.79937402 |
| 26 | Petechiae (HP:0000967) | 2.78123888 |
| 27 | Aplastic anemia (HP:0001915) | 2.74115723 |
| 28 | Deep venous thrombosis (HP:0002625) | 2.73443711 |
| 29 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.66719771 |
| 30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.66719771 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 2.64048465 |
| 32 | Polycythemia (HP:0001901) | 2.63788818 |
| 33 | Cholecystitis (HP:0001082) | 2.62792052 |
| 34 | Abnormal gallbladder physiology (HP:0012438) | 2.62792052 |
| 35 | Vertebral compression fractures (HP:0002953) | 2.62565380 |
| 36 | Hyperammonemia (HP:0001987) | 2.62235320 |
| 37 | Increased hepatocellular lipid droplets (HP:0006565) | 2.60383428 |
| 38 | Menorrhagia (HP:0000132) | 2.59346470 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 2.57738025 |
| 40 | Degeneration of anterior horn cells (HP:0002398) | 2.57416840 |
| 41 | Abnormality of the anterior horn cell (HP:0006802) | 2.57416840 |
| 42 | Abnormal hemoglobin (HP:0011902) | 2.51168019 |
| 43 | Xanthomatosis (HP:0000991) | 2.45270388 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 2.44100035 |
| 45 | Cholelithiasis (HP:0001081) | 2.42304809 |
| 46 | Cortical dysplasia (HP:0002539) | 2.33796271 |
| 47 | Prolonged bleeding time (HP:0003010) | 2.31372306 |
| 48 | Nausea (HP:0002018) | 2.31109510 |
| 49 | Secondary amenorrhea (HP:0000869) | 2.23518408 |
| 50 | Diaphragmatic weakness (HP:0009113) | 2.22980838 |
| 51 | Megaloblastic anemia (HP:0001889) | 2.22948944 |
| 52 | Abnormal platelet function (HP:0011869) | 2.21213523 |
| 53 | Impaired platelet aggregation (HP:0003540) | 2.21213523 |
| 54 | Hypolipoproteinemia (HP:0010981) | 2.21196054 |
| 55 | Hyperglycinemia (HP:0002154) | 2.19284289 |
| 56 | Onycholysis (HP:0001806) | 2.19059490 |
| 57 | Paralysis (HP:0003470) | 2.18906109 |
| 58 | Shoulder girdle muscle weakness (HP:0003547) | 2.17991191 |
| 59 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.17928864 |
| 60 | Single umbilical artery (HP:0001195) | 2.17928864 |
| 61 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.17928864 |
| 62 | Epistaxis (HP:0000421) | 2.14273115 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.12412190 |
| 64 | Hypoplasia of the pons (HP:0012110) | 2.12402030 |
| 65 | Chromsome breakage (HP:0040012) | 2.12242224 |
| 66 | Brushfield spots (HP:0001088) | 2.11556614 |
| 67 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.10715238 |
| 68 | Hypoglycemic coma (HP:0001325) | 2.10450842 |
| 69 | Abnormality of alanine metabolism (HP:0010916) | 2.10131314 |
| 70 | Hyperalaninemia (HP:0003348) | 2.10131314 |
| 71 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.10131314 |
| 72 | Abnormality of nucleobase metabolism (HP:0010932) | 2.09094569 |
| 73 | Abnormal gallbladder morphology (HP:0012437) | 2.08562681 |
| 74 | Multiple enchondromatosis (HP:0005701) | 2.08126431 |
| 75 | Reduced antithrombin III activity (HP:0001976) | 2.07197182 |
| 76 | Medulloblastoma (HP:0002885) | 2.05046883 |
| 77 | Cerebral palsy (HP:0100021) | 2.04169921 |
| 78 | Abnormal protein glycosylation (HP:0012346) | 2.02423501 |
| 79 | Abnormal glycosylation (HP:0012345) | 2.02423501 |
| 80 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.02423501 |
| 81 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.02423501 |
| 82 | Gonadal dysgenesis (HP:0000133) | 2.02219900 |
| 83 | Global brain atrophy (HP:0002283) | 2.01837925 |
| 84 | Thrombocytosis (HP:0001894) | 2.00555498 |
| 85 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.99727818 |
| 86 | Increased serum lactate (HP:0002151) | 1.98329824 |
| 87 | Orthostatic hypotension (HP:0001278) | 1.97965180 |
| 88 | Type I transferrin isoform profile (HP:0003642) | 1.97833685 |
| 89 | Premature rupture of membranes (HP:0001788) | 1.97457996 |
| 90 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.97308676 |
| 91 | Abnormality of chromosome stability (HP:0003220) | 1.95387675 |
| 92 | Short middle phalanx of the 5th finger (HP:0004220) | 1.95353418 |
| 93 | Hypochromic microcytic anemia (HP:0004840) | 1.94179138 |
| 94 | Abnormality of the Achilles tendon (HP:0005109) | 1.91746563 |
| 95 | Delayed CNS myelination (HP:0002188) | 1.91039631 |
| 96 | Increased serum pyruvate (HP:0003542) | 1.90945340 |
| 97 | Ileus (HP:0002595) | 1.89801629 |
| 98 | Poor head control (HP:0002421) | 1.88041658 |
| 99 | Hypoglycemic seizures (HP:0002173) | 1.87864524 |
| 100 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.87007932 |
| 101 | Renal Fanconi syndrome (HP:0001994) | 1.85968972 |
| 102 | Microcytic anemia (HP:0001935) | 1.85785250 |
| 103 | Autoimmune thrombocytopenia (HP:0001973) | 1.84826309 |
| 104 | Gout (HP:0001997) | 1.84413186 |
| 105 | Increased muscle lipid content (HP:0009058) | 1.81844414 |
| 106 | Postnatal microcephaly (HP:0005484) | 1.80931370 |
| 107 | Cutaneous photosensitivity (HP:0000992) | 1.80853794 |
| 108 | Myelodysplasia (HP:0002863) | 1.80660700 |
| 109 | Ketosis (HP:0001946) | 1.80249504 |
| 110 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.80024338 |
| 111 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.76451770 |
| 112 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.76451770 |
| 113 | Basal cell carcinoma (HP:0002671) | 1.75676440 |
| 114 | Insomnia (HP:0100785) | 1.75580744 |
| 115 | Overlapping toe (HP:0001845) | 1.73851960 |
| 116 | Selective tooth agenesis (HP:0001592) | 1.72824176 |
| 117 | Abnormality of the pons (HP:0007361) | 1.72690780 |
| 118 | Increased intramyocellular lipid droplets (HP:0012240) | 1.72261632 |
| 119 | Abnormal hair whorl (HP:0010721) | 1.72191324 |
| 120 | Achilles tendon contracture (HP:0001771) | 1.71884941 |
| 121 | Pancytopenia (HP:0001876) | 1.71855974 |
| 122 | Abnormality of the gallbladder (HP:0005264) | 1.71821419 |
| 123 | Abnormality of the umbilical cord (HP:0010881) | 1.71747784 |
| 124 | Protrusio acetabuli (HP:0003179) | 1.71449891 |
| 125 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.69092306 |
| 126 | Meckel diverticulum (HP:0002245) | 1.68711990 |
| 127 | Abnormality of purine metabolism (HP:0004352) | 1.68231626 |
| 128 | Hepatocellular necrosis (HP:0001404) | 1.66546567 |
| 129 | Hypoparathyroidism (HP:0000829) | 1.65944935 |
| 130 | Symptomatic seizures (HP:0011145) | 1.65591595 |
| 131 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.65584854 |
| 132 | Abnormality of methionine metabolism (HP:0010901) | 1.64955828 |
| 133 | Cerebellar dysplasia (HP:0007033) | 1.64513630 |
| 134 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.64137317 |
| 135 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.64078787 |
| 136 | Abnormality of the thoracic spine (HP:0100711) | 1.63589244 |
| 137 | Nonimmune hydrops fetalis (HP:0001790) | 1.63533355 |
| 138 | Progressive muscle weakness (HP:0003323) | 1.63371485 |
| 139 | Duodenal stenosis (HP:0100867) | 1.63112356 |
| 140 | Small intestinal stenosis (HP:0012848) | 1.63112356 |
| 141 | Thrombophlebitis (HP:0004418) | 1.62799287 |
| 142 | Lipid accumulation in hepatocytes (HP:0006561) | 1.61815109 |
| 143 | Prolonged partial thromboplastin time (HP:0003645) | 1.61787148 |
| 144 | Ankle contracture (HP:0006466) | 1.61746949 |
| 145 | Abnormality of the common coagulation pathway (HP:0010990) | 1.61436362 |
| 146 | Delusions (HP:0000746) | 1.61374180 |
| 147 | Hyperlipoproteinemia (HP:0010980) | 1.61111966 |
| 148 | CNS demyelination (HP:0007305) | 1.60921834 |
| 149 | Abnormality of the tricuspid valve (HP:0001702) | 1.60881759 |
| 150 | Abnormality of serum amino acid levels (HP:0003112) | 1.60871693 |
| 151 | Hepatic necrosis (HP:0002605) | 1.60746462 |
| 152 | Pelvic girdle muscle weakness (HP:0003749) | 1.60175654 |
| 153 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.58143702 |
| 154 | Abnormality of glycolysis (HP:0004366) | 1.58024130 |
| 155 | Neoplasm of the liver (HP:0002896) | 1.57689797 |
| 156 | Tetraparesis (HP:0002273) | 1.56766590 |
| 157 | Hypertensive crisis (HP:0100735) | 1.56109711 |
| 158 | Missing ribs (HP:0000921) | 1.54096146 |
| 159 | Termporal pattern (HP:0011008) | 1.53648439 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.15093329 |
| 2 | CDC7 | 3.63167246 |
| 3 | SCYL2 | 3.49364963 |
| 4 | WEE1 | 3.40785016 |
| 5 | BUB1 | 3.28879622 |
| 6 | EIF2AK1 | 3.18876926 |
| 7 | PKN2 | 2.80387529 |
| 8 | MAP3K10 | 2.59649877 |
| 9 | VRK2 | 2.53742699 |
| 10 | EEF2K | 2.23901681 |
| 11 | NEK2 | 2.18009660 |
| 12 | NEK1 | 2.07413862 |
| 13 | BCKDK | 2.00332736 |
| 14 | TRIB3 | 1.92735152 |
| 15 | FLT3 | 1.88756031 |
| 16 | EIF2AK3 | 1.87021964 |
| 17 | ERN1 | 1.81591889 |
| 18 | ACVR1B | 1.81045000 |
| 19 | MAP3K11 | 1.79807260 |
| 20 | TAF1 | 1.78551065 |
| 21 | KDR | 1.70868246 |
| 22 | PLK4 | 1.70620417 |
| 23 | RPS6KA4 | 1.69059735 |
| 24 | PIM2 | 1.67543858 |
| 25 | BCR | 1.66599494 |
| 26 | DYRK3 | 1.66587843 |
| 27 | BRSK2 | 1.61383572 |
| 28 | VRK1 | 1.59200609 |
| 29 | TESK2 | 1.58103087 |
| 30 | ZAK | 1.52608816 |
| 31 | CCNB1 | 1.47942051 |
| 32 | MAP2K7 | 1.46482935 |
| 33 | MAP3K8 | 1.43875795 |
| 34 | TRIM28 | 1.40661680 |
| 35 | CDK4 | 1.39881491 |
| 36 | LRRK2 | 1.39485918 |
| 37 | BRSK1 | 1.36984217 |
| 38 | STK10 | 1.33685823 |
| 39 | TIE1 | 1.31845247 |
| 40 | MAP4K2 | 1.30980423 |
| 41 | MST4 | 1.26285145 |
| 42 | MAP4K1 | 1.24492929 |
| 43 | TYK2 | 1.23238020 |
| 44 | CDK19 | 1.21138511 |
| 45 | TGFBR1 | 1.21040804 |
| 46 | PAK4 | 1.18332102 |
| 47 | MKNK1 | 1.17768464 |
| 48 | PLK1 | 1.12450252 |
| 49 | CSNK1G3 | 1.11344169 |
| 50 | ATR | 1.09355741 |
| 51 | TLK1 | 1.04573259 |
| 52 | AURKB | 1.04459397 |
| 53 | ZAP70 | 1.04354734 |
| 54 | RPS6KB2 | 1.04244689 |
| 55 | TTK | 1.02830444 |
| 56 | CLK1 | 1.02253215 |
| 57 | RAF1 | 0.98841092 |
| 58 | GRK6 | 0.96542771 |
| 59 | MAP3K5 | 0.95749346 |
| 60 | PASK | 0.95239341 |
| 61 | CSNK1G1 | 0.94815593 |
| 62 | TBK1 | 0.92753803 |
| 63 | CDK7 | 0.92606324 |
| 64 | AURKA | 0.92426764 |
| 65 | ABL2 | 0.92178286 |
| 66 | MAP2K3 | 0.90253299 |
| 67 | JAK3 | 0.85531326 |
| 68 | DAPK1 | 0.85352906 |
| 69 | ERBB4 | 0.84430835 |
| 70 | CSNK1A1L | 0.84409906 |
| 71 | TAOK2 | 0.83388357 |
| 72 | TESK1 | 0.82545887 |
| 73 | PRPF4B | 0.79650274 |
| 74 | JAK2 | 0.78809688 |
| 75 | CSNK1G2 | 0.78312969 |
| 76 | MAPK11 | 0.76641894 |
| 77 | MAP3K12 | 0.74961287 |
| 78 | CDK8 | 0.73644271 |
| 79 | IRAK3 | 0.72956735 |
| 80 | PIM1 | 0.70302890 |
| 81 | KSR2 | 0.70057184 |
| 82 | DYRK2 | 0.69399899 |
| 83 | STK3 | 0.69210577 |
| 84 | CDK6 | 0.67045215 |
| 85 | SIK1 | 0.65496612 |
| 86 | EIF2AK2 | 0.65354340 |
| 87 | ERBB3 | 0.65288894 |
| 88 | TSSK6 | 0.63905266 |
| 89 | STK4 | 0.63390727 |
| 90 | NUAK1 | 0.62186540 |
| 91 | LATS1 | 0.61674754 |
| 92 | CHEK2 | 0.61644590 |
| 93 | MAP3K4 | 0.59593055 |
| 94 | MAP3K6 | 0.57402744 |
| 95 | CHEK1 | 0.56294062 |
| 96 | KSR1 | 0.56281379 |
| 97 | DYRK1B | 0.56251655 |
| 98 | SRPK1 | 0.55278644 |
| 99 | MAPKAPK3 | 0.54222093 |
| 100 | PTK6 | 0.53568897 |
| 101 | STK16 | 0.53496045 |
| 102 | RPS6KA5 | 0.52453666 |
| 103 | PBK | 0.51788487 |
| 104 | TGFBR2 | 0.51240718 |
| 105 | BMX | 0.49942339 |
| 106 | CSNK2A2 | 0.49468295 |
| 107 | MET | 0.48701732 |
| 108 | CSNK2A1 | 0.46627289 |
| 109 | BRD4 | 0.46511594 |
| 110 | KIT | 0.46328162 |
| 111 | CDK1 | 0.45997045 |
| 112 | PRKDC | 0.45831026 |
| 113 | FGFR4 | 0.45812143 |
| 114 | CDK14 | 0.44832597 |
| 115 | TAOK1 | 0.42842678 |
| 116 | MATK | 0.42757535 |
| 117 | CDK2 | 0.41743415 |
| 118 | RET | 0.41647987 |
| 119 | CDK18 | 0.41596005 |
| 120 | PLK2 | 0.41586185 |
| 121 | NEK9 | 0.40285580 |
| 122 | ATM | 0.39246081 |
| 123 | CDK9 | 0.39170271 |
| 124 | CDK15 | 0.38144515 |
| 125 | EPHA2 | 0.37908751 |
| 126 | AKT2 | 0.36650170 |
| 127 | CDK11A | 0.36164060 |
| 128 | PAK1 | 0.35860130 |
| 129 | CDK12 | 0.35426520 |
| 130 | LIMK1 | 0.35202139 |
| 131 | PAK2 | 0.34737746 |
| 132 | MAP3K13 | 0.34364561 |
| 133 | BRAF | 0.31861483 |
| 134 | CAMKK1 | 0.30452935 |
| 135 | BTK | 0.30339044 |
| 136 | MINK1 | 0.30275533 |
| 137 | PLK3 | 0.28682082 |
| 138 | LYN | 0.27543796 |
| 139 | DAPK2 | 0.27442868 |
| 140 | CSF1R | 0.27132710 |
| 141 | SYK | 0.26965405 |
| 142 | ARAF | 0.25260579 |
| 143 | ALK | 0.24423747 |
| 144 | ERBB2 | 0.23919233 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.79934244 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.23283591 |
| 3 | One carbon pool by folate_Homo sapiens_hsa00670 | 3.03124117 |
| 4 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 3.02435359 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.81085122 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 2.29948196 |
| 7 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.26219129 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.23623472 |
| 9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.20682072 |
| 10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.16512234 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.14599003 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.14116523 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 2.08752790 |
| 14 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.02599036 |
| 15 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.02210582 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.98514044 |
| 17 | Protein export_Homo sapiens_hsa03060 | 1.94040609 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.92495491 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.88215372 |
| 20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.86890597 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.84139819 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.80896076 |
| 23 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78993554 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.75745242 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.75119949 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.72558563 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.72506305 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.66343042 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65868903 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.63692216 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.57714421 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.46754125 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.43340578 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.42824392 |
| 35 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.42380752 |
| 36 | RNA polymerase_Homo sapiens_hsa03020 | 1.40600870 |
| 37 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37977219 |
| 38 | Carbon metabolism_Homo sapiens_hsa01200 | 1.37292758 |
| 39 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.33840773 |
| 40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.29495981 |
| 41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.29238956 |
| 42 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.26252275 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21999306 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21858291 |
| 45 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.20569006 |
| 46 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.18827017 |
| 47 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.17986273 |
| 48 | Basal transcription factors_Homo sapiens_hsa03022 | 1.10478967 |
| 49 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99619953 |
| 50 | Peroxisome_Homo sapiens_hsa04146 | 0.99292012 |
| 51 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.95638349 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94482266 |
| 53 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.94442481 |
| 54 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92647892 |
| 55 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90888567 |
| 56 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.89456762 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.87504859 |
| 58 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85422166 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84926571 |
| 60 | RNA degradation_Homo sapiens_hsa03018 | 0.84539236 |
| 61 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84200207 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.84042243 |
| 63 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81776563 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.79069003 |
| 65 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.77926847 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.77416649 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75339841 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.74144344 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68212245 |
| 70 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67857263 |
| 71 | Bile secretion_Homo sapiens_hsa04976 | 0.66563346 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66560496 |
| 73 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65439508 |
| 74 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64779935 |
| 75 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63841229 |
| 76 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.63773845 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63397869 |
| 78 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.63146374 |
| 79 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61918029 |
| 80 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.60773521 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.57141354 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.57058173 |
| 83 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.56523674 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56333140 |
| 85 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.56269633 |
| 86 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55148135 |
| 87 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54129177 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.53924525 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.52984401 |
| 90 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52968569 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51683364 |
| 92 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.50625356 |
| 93 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.50195474 |
| 94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49108816 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48366407 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47163267 |
| 97 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.45233944 |
| 98 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44160006 |
| 99 | Galactose metabolism_Homo sapiens_hsa00052 | 0.44158923 |
| 100 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.43739746 |
| 101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42691030 |
| 102 | ABC transporters_Homo sapiens_hsa02010 | 0.41668795 |
| 103 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.41415939 |
| 104 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.41238417 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40766518 |
| 106 | Apoptosis_Homo sapiens_hsa04210 | 0.39608032 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.38707543 |
| 108 | Retinol metabolism_Homo sapiens_hsa00830 | 0.38326949 |
| 109 | Parkinsons disease_Homo sapiens_hsa05012 | 0.36506705 |
| 110 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35266587 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.34261432 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34239358 |
| 113 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.33800863 |
| 114 | Hepatitis B_Homo sapiens_hsa05161 | 0.32774990 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.32122186 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.29872823 |
| 117 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.28625078 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28054342 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.27075416 |
| 120 | Alzheimers disease_Homo sapiens_hsa05010 | 0.26832440 |
| 121 | HTLV-I infection_Homo sapiens_hsa05166 | 0.25703761 |
| 122 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.25681203 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25236835 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.24083551 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.23451485 |
| 126 | Lysine degradation_Homo sapiens_hsa00310 | 0.22459978 |
| 127 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.21964233 |
| 128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.20749012 |

